Waters Co. (NYSE:WAT) Shares Sold by Lawson Kroeker Investment Management Inc. NE

Lawson Kroeker Investment Management Inc. NE decreased its position in Waters Co. (NYSE:WAT) by 22.0% in the 4th quarter, Holdings Channel reports. The fund owned 11,994 shares of the medical instruments supplier’s stock after selling 3,377 shares during the period. Lawson Kroeker Investment Management Inc. NE’s holdings in Waters were worth $4,450,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of WAT. Kennebec Savings Bank acquired a new stake in Waters in the third quarter valued at approximately $33,000. Ashton Thomas Securities LLC acquired a new stake in Waters in the third quarter valued at approximately $35,000. Fortitude Family Office LLC grew its position in Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 66 shares in the last quarter. R Squared Ltd acquired a new stake in Waters in the fourth quarter valued at approximately $63,000. Finally, Itau Unibanco Holding S.A. grew its position in shares of Waters by 63.2% during the third quarter. Itau Unibanco Holding S.A. now owns 186 shares of the medical instruments supplier’s stock worth $67,000 after buying an additional 72 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

WAT has been the subject of a number of recent analyst reports. TD Cowen raised their price target on shares of Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Scotiabank assumed coverage on shares of Waters in a report on Monday, December 23rd. They issued a “sector perform” rating and a $430.00 price objective for the company. Cfra set a $389.00 price objective on shares of Waters in a report on Thursday, October 17th. Sanford C. Bernstein raised shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price objective for the company in a report on Friday, January 10th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $384.71.

Waters Price Performance

Shares of NYSE WAT opened at $404.55 on Thursday. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $419.28. The firm’s 50-day simple moving average is $385.13 and its 200 day simple moving average is $356.89. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14. The stock has a market cap of $24.02 billion, a P/E ratio of 38.60, a P/E/G ratio of 7.17 and a beta of 1.01.

Waters (NYSE:WAT) last issued its quarterly earnings data on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share for the quarter, beating analysts’ consensus estimates of $2.68 by $0.25. Waters had a net margin of 21.43% and a return on equity of 49.93%. The business had revenue of $740.30 million for the quarter, compared to analysts’ expectations of $712.99 million. During the same period in the previous year, the business earned $2.84 earnings per share. The company’s revenue was up 4.0% on a year-over-year basis. Equities analysts expect that Waters Co. will post 11.79 EPS for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.